Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100051086Phase 4Recruiting
Phase 4, randomised, open-label trial in neutropenia comparing PEG-rhG-CSF group with rhG-CSF group (2 arms). Primary endpoint: Neutrophil recovery time. Started Sep 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100051086.